Trial Profile
Comparison of Pharmacodynamics and Pharmacokinetics of the Two Fast-acting Insulin Analogs Insulin Glulisine and Insulin Aspart in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin glulisine (Primary)
- Indications Gestational diabetes; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Sep 2009 New trial record